Left ventricular outflow tract obstruction, narrow definition

Q17_LVOTO_NARROW

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q23, Q24.4, Q25.1, Q25.20, Q25.3, Q25.40 Hospital discharge: ICD-9 — 7463A\|7464A\|7463D\|7465A\|7466A\|7467A\|7468X\|7463X\|7471A\|7472B\|7471B Hospital discharge: excluded ICD-10 — Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875 Hospital discharge: excluded ICD-9 — 758\|7595\|75683 Cause of death: ICD-10 — Q23, Q24.4, Q25.1, Q25.20, Q25.3, Q25.40 Cause of death: ICD-9 — 7463A\|7464A\|7463D\|7465A\|7466A\|7467A\|7468X\|7463X\|7471A\|7472B\|7471B Cause of death: excluded ICD-10 — Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875 Cause of death: excluded ICD-9 — 758\|7595\|75683 2 out of 7 registries used, show all original rules.	1849
4. Check minimum number of events None	1849
5. Include endpoints None	1849
6. Filter based on genotype QC (FinnGen only)	1849

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF7

NAME	Q17_LVOTO_NARROW
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q230\|Q2310\|Q2311\|Q2320\|Q2321\|Q233\|Q234\|Q238\|Q239\|Q244\|Q251\|Q2520\|Q253\|Q2540
HD_ICD_9	7463A\|7464A\|7463D\|7465A\|7466A\|7467A\|7468X\|7463X\|7471A\|7472B\|7471B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875
HD_ICD_9_EXCL	758\|7595\|75683
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q230\|Q2310\|Q2311\|Q2320\|Q2321\|Q233\|Q234\|Q238\|Q239\|Q244\|Q251\|Q2520\|Q253\|Q2540
COD_ICD_9	7463A\|7464A\|7463D\|7465A\|7466A\|7467A\|7468X\|7463X\|7471A\|7472B\|7471B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875
COD_ICD_9_EXCL	758\|7595\|75683
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Left ventricular outflow tract obstruction, narrow definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Bicuspidal aortic valve syndrome

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14391	5274	9068
Only index persons	11312	4077	7235
Unadjusted period prevalence (%)
Whole population	0.22	0.15	0.25
Only index persons	0.23	0.15	0.28
Median age at first event (years)
Whole population	18.56	15.60	20.08
Only index persons	29.81	26.79	31.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1849	666	1183
Unadjusted period prevalence (%)	0.42	0.23	0.52
Median age at first event (years)	47.45	41.65	50.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1631: Matched controls
16295

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q23.11

ICD-10 Finland

Bicuspid aortic valve

16384.0

323.0

1161

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

10.8

323.0

959

1904

Q25.1

ICD-10 Finland

Coarctation of aorta

+∞

323.0

313

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

17.7

323.0

567

477

B01AA03

ATC

warfarin; systemic

10.8

323.0

763

1231

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

27.0

323.0

515

274

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

10.3

323.0

772

1306

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

36.7

323.0

441

163

I35.0

ICD-10 Finland

Aortic (valve) stenosis

33.6

323.0

570

256

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

40.2

323.0

633

253

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

55.0

318.9

379

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

50.2

313.9

380

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

81.4

228.0

255

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

5.9

189.6

650

1637

WX872

NOMESCO Finland

Intensive care

11.6

167.0

330

348

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.6

157.9

544

1327

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.0

133.8

365

643

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

130.6

930

4350

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

+∞

129.9

123

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

33.9

127.6

168

C07AB07

ATC

bisoprolol; oral

3.6

126.9

888

4061

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

32.1

125.9

168

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

+∞

121.3

115

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.2

120.7

319

531

K83

ICPC

Heart valve disease NOS

36.8

117.0

151

201

Kela drug reimbursment

Chronic cardiac insufficiency

10.5

111.2

228

248

PD5BD

NOMESCO Finland

Extensive CT of aorta

22.0

103.6

154

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

116.6

101.3

109

74719

ICD-8 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta

960.9

93.8

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

19.3

91.6

142

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

77.4

90.4

102

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

86.0

391

1169

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.7

83.5

206

301

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

18.0

80.0

127

XF402

NOMESCO Finland

ECG with work load test

4.6

78.7

305

776

XF404

NOMESCO Finland

Ambulatory ECG

4.8

78.4

293

718

7471A

ICD-9 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]

+∞

76.6

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

58.0

74.8

C03CA01

ATC

furosemide; systemic

3.2

74.2

471

1815

B01AB05

ATC

enoxaparin; parenteral

2.9

71.3

555

2447

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

48.4

68.4

TPH07

NOMESCO Finland

Cathetrisation of artery

4.2

68.0

289

796

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

67.3

418

1568

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.3

65.6

393

1433

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

64.6

604

2942

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

39.8

60.3

Congenital heart failure surgery

160.9

59.3

XF640

NOMESCO Finland

10.4

59.1

119

122

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.1

56.5

191

413

Catheterization and pressure measurement of the left side of the heart

15.8

56.2

AB1

AVR mechanical

42.3

55.5

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

30.5

54.5

FM2CE

NOMESCO Finland

8.7

54.4

121

148

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

29.2

51.7

XFE00

NOMESCO Finland

Epicardial ultrasonography

8.6

51.6

116

144

TFP20

NOMESCO Finland

Cardiodefibrillation

4.6

51.6

194

468

C03DA01

ATC

spironolactone; oral

3.9

50.9

230

659

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

+∞

50.2

Q23.3

ICD-10 Finland

Congenital mitral insufficiency

+∞

49.2

Q24.4

ICD-10 Finland

Congenital subaortic stenosis

+∞

48.1

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

47.8

684

3989

Q25.3

ICD-10 Finland

Stenosis of aorta

480.9

47.6

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

16.0

47.5

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

14.1

46.9

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

33.3

46.6

PD5BG

NOMESCO Finland

MRI examination of thoracal and abdominal aortta with high intensity magnet

164.6

46.0

XF600

NOMESCO Finland

Bloodpressure measurement

3.8

45.5

207

594

K84

ICPC

Heart disease other

8.3

44.2

101

129

Q25.40

ICD-10 Finland

Aortic hypoplasia

+∞

42.9

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

18.0

42.2

C01AA05

ATC

digoxin; systemic

4.6

42.0

154

360

R4110

NOMESCO Finland

Physiotherapy

2.3

41.9

509

2711

Q21.10

ICD-10 Finland

Persistent ostium secundum

12.6

41.9

AN1

Coronary angiography

3.3

40.9

226

755

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

19.7

40.3

Z2221

NOMESCO Finland

Medical doctor

2.2

40.3

516

2807

Catheterization and pressure measurement of the right side of the heart

39.6

39.8

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.7

39.4

142

326

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

75.4

39.1

XF622

NOMESCO Finland

Measurement of minute volume of heart

26.5

39.1

PD5DG

NOMESCO Finland

Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

73.3

38.1

7463A

ICD-9 Finland

Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]

+∞

37.6

I44.2

ICD-10 Finland

Atrioventricular block, complete

9.0

37.5

WX402

NOMESCO Finland

General anaesthesia

2.4

37.0

370

1774

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

32.9

36.7

I50.9

ICD-10 Finland

Heart failure, unspecified

3.3

36.0

196

645

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.3

36.0

114

227

C01BD01

ATC

amiodarone; systemic

6.8

36.0

143

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.0

35.9

103

182

Q25.0

ICD-10 Finland

Patent ductus arteriosus

16.2

35.7

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

29.0

35.6

J01CA04

ATC

amoxicillin; systemic

2.2

34.9

1366

11370

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

52.5

34.5

FDA00

NOMESCO Finland

Aortoplasty and aorto-pulmonary shunt for HLHS

+∞

33.4

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

57.0

33.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.9

32.5

164

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.3

32.5

173

559

WX892

NOMESCO Finland

Monitored bed care

3.2

32.1

180

604

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

48.5

31.6

ZXD05

NOMESCO Finland

Urgent procedure

2.0

31.0

523

3122

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.3

30.9

109

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

18.6

30.6

AB2

AVR bio, stent

28.0

30.3

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

29.2

29.9

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

29.2

29.9

WZC30

NOMESCO Finland

Teaching

2.5

29.6

264

1178

WW502

NOMESCO Finland

Autotransfusion

21.0

29.2

C09AA05

ATC

ramipril; oral

2.2

28.9

355

1851

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

12.5

28.3

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

27.6

576

3685

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

27.5

703

4812

I97.0

ICD-10 Finland

Postcardiotomy syndrome

20.5

27.0

C07AB02

ATC

metoprolol; systemic

2.3

26.7

283

1370

I35.8

ICD-10 Finland

Other aortic valve disorders

34.7

26.5

K78

ICPC

Atrial fibrillation/flutter

3.5

26.4

132

405

AJ2

Reconstruction of the ascending aorta

52.6

26.3

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

14.5

26.2

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

5.1

26.1

171

PD5AD

NOMESCO Finland

CT of aorta

8.5

25.9

K99

ICPC

Cardiovascular disease other

6.2

25.9

119

74673

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae aortae

264.4

25.8

ZXE00

NOMESCO Finland

One hour or less

1.8

25.7

652

4419

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

4.8

25.5

189

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

25.5

25.3

5513

FHL

Coarctation resection, plastic or bypass

+∞

25.1

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

39.5

24.9

Aortic Valve Replacement (AVR)

43.5

24.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

24.3

471

2907

FCA75

NOMESCO Finland

Valve-sparing repair of aortic root (David, Yacoub)

49.1

24.3

5253

FHL

Cardiac lung machine

14.0

24.1

5273

FHL

Repair with flap prosthesis or graft

42.1

23.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

23.2

360

2044

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.0

23.1

253

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

18.8

23.1

7464A

ICD-9 Finland

Other congenital anomalies of heart, Congenital insufficiency of aortic valve

+∞

23.0

FDJ00

NOMESCO Finland

End to end reconstruction of aorta for coarctation

+∞

23.0

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.1

22.9

280

1440

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

16.7

22.7

Q20.48

ICD-10 Finland

Single ventricle

84.6

22.7

207

Kela drug reimbursment

Chronic arrhythmias

2.5

22.6

199

873

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

22.4

381

2231

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

52.7

22.1

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

8.0

22.1

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

6.6

22.0

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

13.4

22.0

FMD40

NOMESCO Finland

Replacement of aortic root using pulmonary autograft and reimplantation of coronary arteries (Ross)

+∞

21.9

Q23.8

ICD-10 Finland

Other congenital malformations of aortic and mitral valves

+∞

21.9

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

81.2

21.7

FAE10

NOMESCO Finland

Bidirectional anastomosis between superior vena cava and pulmonary artery

222.7

21.6

Q25.48

ICD-10 Finland

Other congenital malformations of the aorta

222.7

21.6

WX882

NOMESCO Finland

High dependency care

3.3

21.1

112

360

7463D

ICD-9 Finland

Other congenital anomalies of heart, Congenital stenosis of aortic valve[BIKUSPINEN AORTALÄPPÄ]

+∞

20.9

FDJ42

NOMESCO Finland

Percutaneous transluminal angioplasty of thoracic aorta in coarctation

+∞

20.9

5255

FHL

Deep hypothermia (<20 °) with cardiopulmonary resuscitation

212.4

20.6

I34.1

ICD-10 Finland

Mitral (valve) prolapse

5.2

20.6

130

Q20.1

ICD-10 Finland

Double outlet right ventricle

111.4

20.6

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

42.2

20.5

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.3

20.3

107

342

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

19.1

20.0

Z94.1

ICD-10 Finland

Heart transplant status

23.7

20.0

Q21.0

ICD-10 Finland

Ventricular septal defect

36.2

19.8

PD5CM

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet

202.2

19.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

19.5

337

1973

FXA13

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion

+∞

18.8

Q23.9

ICD-10 Finland

Congenital malformation of aortic and mitral valves, unspecified

+∞

18.8

I37.0

ICD-10 Finland

Pulmonary valve stenosis

101.1

18.6

WX704

NOMESCO Finland

Intubation

2.7

18.5

135

532

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

4.5

18.2

149

RS224

NOMESCO Finland

8.7

18.2

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

22.0

18.2

C09CA01

ATC

losartan; oral

1.9

18.1

314

1835

C09AA02

ATC

enalapril; systemic

2.0

17.7

260

1431

FBE10

NOMESCO Finland

Expansion or reconstruction of pulmonary artery using patch

96.0

17.6

C07AA07

ATC

sotalol; systemic

4.3

17.4

156

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1201

3360

8.34

307.65

5.4

3.2

ng/l

890.8

1216.5

2.20

1117

2832

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

490

981

6.43

245.26

4.2

2.9

ng/l

166.6

177.3

0.23

456

878

(3018677) aPTT in Platelet poor plasma by Coagulation assay

764

2264

5.05

244.55

4.7

2.9

31.1

30.0

4.11

748

2207

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

501

1094

5.91

227.44

2.4

2.2

ug/l

17.7

7.8

10.89

484

984

(3032080) INR in Blood by Coagulation assay

1204

5333

4.60

221.34

27.4

8.1

inr

1.9

1.2

55.29

358

1566

(3022217) INR in Platelet poor plasma by Coagulation assay

562

1465

5.07

206.39

55.9

20.4

inr

2.2

1.3

10.48

222

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

626

2548

3.20

112.77

5.7

3.6

ng/l

1944.4

609.5

7.78

562

1879

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

246

578

4.75

98.10

5.7

4.5

g/l

3.0

3.4

3.33

240

552

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

208

430

5.32

96.41

12.9

4.4

u/ml

0.3

0.12

137

243

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

430

1523

3.38

95.85

3.7

4.8

u/l

287.3

256.3

2.12

414

1451

(3020779) Urea [Moles/volume] in Serum or Plasma

422

1505

3.34

92.76

9.6

10.0

mmol/l

7.6

8.3

1.45

412

1448

(3044889) 12 lead EKG panel

1422

9785

2.96

85.99

5.9

3.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

14.99

83.88

9.6

6.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

695

3429

2.64

82.96

2.8

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1073

6537

2.53

81.27

4.7

4.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

15.77

80.54

8.5

7.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

753

3967

2.51

77.14

2.9

2.2

u/l

381.8

284.6

1.36

722

3755

(3012095) Magnesium [Moles/volume] in Serum or Plasma

522

2354

2.70

73.28

7.4

5.2

mmol/l

0.8

1.75

507

2233

(3013826) Glucose [Moles/volume] in Serum or Plasma

1255

8459

2.50

72.72

9.8

5.6

mmol/l

6.5

6.6

1.52

1209

7927

(3044640) Blood type and Crossmatch panel - Blood

793

4391

2.41

71.50

2.9

2.6

—

(3036489) Thrombin time

230

666

3.80

68.55

4.6

3.8

22.9

22.1

0.94

220

605

(3023368) Bacteria identified in Blood by Culture

690

3659

2.41

67.78

5.4

4.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

830

4885

2.27

62.71

4.1

3.4

ng/l

76.5

58.7

0.53

585

3188

(3016502) Oxygen saturation in Arterial blood

353

1406

2.87

61.94

18.8

9.8

97.4

95.7

6.05

346

1361

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1079

7151

2.22

59.77

7.3

6.8

umol/l

15.9

13.4

3.92

1036

6799

(3027801) Oxygen [Partial pressure] in Arterial blood

370

1542

2.75

59.36

18.3

9.3

kpa

14.2

12.7

4.64

360

1491

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

370

1543

2.75

59.28

18.3

9.3

kpa

5.2

5.1

0.66

361

1488

(3003396) Base excess in Arterial blood by calculation

369

1537

2.75

59.26

18.3

9.3

mmol/l

0.9

1.0

0.15

321

1222

(3002173) Hemoglobin [Mass/volume] in Arterial blood

326

1296

2.84

57.08

17.9

9.9

g/l

113.4

124.9

18.94

321

1251

(3014576) Chloride [Moles/volume] in Serum or Plasma

404

1823

2.56

54.82

10.5

8.2

mmol/l

105.9

104.4

9.32

399

1784

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

16.44

53.06

8.2

9.8

—

(3033658) Prothrombin time (PT) actual/Normal

666

3800

2.18

52.01

6.7

4.9

73.9

89.3

30.73

659

3722

(3022948) Iron [Moles/volume] in Serum or Plasma

447

2193

2.37

50.02

2.9

2.7

umol/l

13.4

13.9

0.52

430

2053

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

400

1903

2.41

47.75

2.9

2.7

22.7

23.8

0.62

355

1664

(3006576) Bicarbonate [Moles/volume] in Blood

10.26

47.03

9.6

7.4

mmol/l

25.9

25.4

0.40

(3004789) Transferrin [Mass/volume] in Serum or Plasma

417

2036

2.35

46.84

2.9

2.6

g/l

2.4

1.58

402

1903

(3019550) Sodium [Moles/volume] in Serum or Plasma

1760

15154

4.35

46.58

26.1

15.0

mmol/l

139.3

139.6

7.42

1741

14779

(3023103) Potassium [Moles/volume] in Serum or Plasma

1762

15204

4.37

46.01

25.9

15.0

mmol/l

4.0

4.70

1742

14801

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

219

4.87

44.73

10.7

6.4

mg/l

10.4

10.9

0.48

203

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

213

771

2.99

43.71

25.8

12.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

260

1085

2.62

40.60

3.3

2.6

ml/min/173m2

63.1

71.4

2.19

399

(3004119) Hemoglobin [Mass/volume] in Venous blood

219

843

2.81

40.03

6.2

5.2

g/l

122.6

131.6

6.63

212

824

(3024928) Oxygen saturation in Venous blood

122

332

3.86

39.31

7.1

6.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

294

1355

2.39

36.94

15.9

9.5

mmol/l

1.2

1.4

2.00

287

1290

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

754

4947

1.88

36.61

4.3

3.7

u/l

37.8

37.5

0.02

731

4710

(3000991) Gas panel - Venous blood

326

1591

2.27

35.79

16.2

10.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

329

1631

2.24

34.69

3.7

4.0

1.6

1.7

0.18

312

1489

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

904

6378

1.82

33.93

14.0

7.8

mmol/l

1.2

25.17

865

5871

(3008152) Bicarbonate [Moles/volume] in Arterial blood

202

813

2.67

33.68

18.0

7.9

mmol/l

24.9

24.5

0.87

194

756

(3019060) Gas panel - Arterial blood

206

841

2.63

33.37

13.1

5.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

957

6918

1.79

32.66

12.6

8.2

mmol/l

1.2

22.84

858

5984

(3042936) Bacteria identified in Isolate by Culture

373

2021

2.06

30.98

2.5

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1338

10840

1.85

29.66

8.0

7.4

u/l

81.4

83.9

0.96

1291

10267

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

383

2140

2.00

29.02

2.0

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

552

3481

1.83

28.90

2.5

2.4

mg/l

3.2

2.8

2.01

503

2990

(40761511) CBC panel - Blood by Automated count

1758

15836

3.23

28.71

19.6

11.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

14.89

27.95

9.2

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1768

16012

3.37

27.89

23.4

14.5

umol/l

78.1

76.6

1.21

1768

16007

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

288

3.50

27.44

1.5

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

292

1507

2.11

27.36

2.0

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1702

15160

2.54

26.97

20.2

13.0

mg/l

32.5

23.8

18.42

1474

11643

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

499

3107

1.83

26.92

3.5

2.2

mg/l

1.4

1.2

0.72

358

2322

(3024561) Albumin [Mass/volume] in Serum or Plasma

807

5800

1.69

26.06

6.8

5.8

g/l

35.8

36.2

0.99

764

5453

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

147

572

2.70

26.06

2.0

g/l

1.3

1.5

1.52

497

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1549

13349

1.99

25.92

16.9

11.7

ml/min/173m2

86.5

86.9

0.29

1359

10829

(3002032) Base excess in Venous blood by calculation

315

1711

2.01

25.57

6.6

6.4

mmol/l

1.7

0.01

265

1359

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

289

1523

2.06

25.50

2.1

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

314

1719

2.00

24.88

6.3

6.4

kpa

5.9

0.12

309

1673

(3003694) ABO and Rh group [Type] in Blood

642

4403

1.70

24.25

1.5

—

(3020891) Body temperature

136

546

2.61

22.62

8.6

5.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

116

433

2.79

22.25

1.6

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

830

6285

1.58

20.00

3.2

2.9

ug/l

184.7

130.4

0.42

787

5882

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

260

1432

1.95

19.98

18.5

11.4

mmol/l

24.9

24.8

0.22

260

1426

(3013512) EKG study

526

3624

1.63

18.51

5.6

3.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

127

544

2.43

18.42

3.2

2.1

ug/l

2.4

2.1

0.11

116

493

(3021589) Normoblasts [#/volume] in Blood

896

7010

1.54

18.01

11.6

10.0

e9/l

0.0

0.34

763

5670

(3023520) Reticulocytes [#/volume] in Blood

220

1186

1.97

17.91

3.9

3.5

e9/l

72.7

69.7

0.50

164

879

(3002385) Erythrocyte distribution width [Ratio]

1492

13159

1.69

17.33

26.1

16.1

13.6

13.5

2.19

1473

12907

(40758558) Short blood count panel - Blood

554

3984

1.56

15.81

7.7

7.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

208

1171

1.87

14.78

8.0

7.0

mmol/l

24.0

23.9

0.35

198

1106

(3007853) Bacteria identified in Skin by Aerobe culture

289

1801

1.72

14.58

2.0

1.7

—

(3001604) Monocytes [#/volume] in Blood

955

7792

1.47

14.35

7.7

6.9

e9/l

0.6

0.31

850

6704

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

115

527

2.26

14.31

16.2

6.2

1.7

0.12

110

492

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.44

14.28

11.4

4.2

mg/l

5259.4

78.1

0.49

(3006315) Basophils [#/volume] in Blood

956

7811

1.46

14.20

7.7

6.9

e9/l

0.0

0.30

851

6716

(3013115) Eosinophils [#/volume] in Blood

981

8062

1.46

14.10

8.3

7.3

e9/l

0.2

0.10

882

7080

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

258

1578

1.74

13.89

9.6

6.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1054

8824

1.45

13.46

10.5

9.8

e9/l

4.1

4.0

0.75

942

7636

(3039000) Anion gap in Blood

291

2.64

13.40

22.3

8.8

mmol/l

10.4

11.3

2.46

260

(3051611) Lipemic interference index of Serum or Plasma

140

3.42

13.32

5.6

4.1

—

(3018572) Chloride [Moles/volume] in Blood

292

2.63

13.31

22.3

8.8

mmol/l

106.5

105.5

1.32

261

(3018738) Hemoglobin F/Hemoglobin.total in Blood

5.78

13.21

5.0

4.6

3.3

4.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

400

2.37

12.94

1.7

2.0

—

(3051651) Icteric interference index of Serum or Plasma

109

3.73

12.94

5.6

4.3

—

(44790047)

234

2.80

12.83

1.8

1.9

—

(44790049)

234

2.80

12.83

1.8

1.9

—

(44790048)

234

2.80

12.83

1.8

1.9

—

(44806118)

234

2.80

12.83

1.8

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

968

8025

1.43

12.72

7.8

6.9

e9/l

1.7

2.0

9.98

874

7058

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

667

5166

1.45

12.67

3.8

3.5

—

(3018418) pH of Serum or Plasma

520

3836

1.49

12.66

4.4

4.2

7.4

0.70

106

740

(3013707) Erythrocyte sedimentation rate by Westergren method

1225

10613

1.46

12.62

4.4

4.0

mm/h

10.6

10.2

0.54

1162

9888

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1711

15994

1.93

12.59

12.3

9.9

u/l

28.9

29.1

0.23

1665

15530

(3047181) Lactate [Moles/volume] in Blood

410

2.31

12.25

19.7

7.5

mmol/l

1.2

1.3

0.15

353

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

399

2.32

12.13

1.8

2.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1468

13231

1.53

12.02

4.5

4.2

mu/l

1.9

2.1

0.50

1369

12234

(3007930) Methemoglobin/Hemoglobin.total in Blood

108

519

2.15

11.98

17.2

6.3

0.9

1.13

103

485

(3000850) Epithelial cells [#/volume] in Urine

418

2982

1.52

11.85

2.8

2.7

e6/l

4.4

5.0

0.42

366

2628

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

145

782

1.93

11.72

1.8

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

890

7347

1.41

11.54

7.9

7.1

3.0

2.9

0.39

847

6923

(3007461) Platelets [#/volume] in Blood

1801

17232

2.73

11.48

30.9

18.9

e9/l

235.4

250.1

19.23

1774

16773

(3019069) Monocytes/100 leukocytes in Blood

894

7393

1.40

11.43

8.1

7.3

9.0

8.7

2.26

853

6991

(3022096) Basophils/100 leukocytes in Blood

868

7147

1.40

11.36

7.9

7.2

0.7

0.14

830

6753

(3002582) Erythrocytes [#/volume] in Urine

575

4403

1.44

11.32

3.6

3.4

e6/l

270.5

73.5

0.46

467

3383

(3024731) MCV [Entitic volume]

1801

17244

2.70

11.24

30.8

18.8

90.0

0.26

1786

17039

(3026361) Erythrocytes [#/volume] in Blood

1801

17247

2.70

11.18

30.9

18.9

e12/l

4.5

4.6

24.85

1770

16750

(3010813) Leukocytes [#/volume] in Blood

1801

17251

2.69

11.09

30.9

18.9

e9/l

6.8

6.7

1.49

1771

16756

(3000963) Hemoglobin [Mass/volume] in Blood

1801

17253

2.68

11.05

31.5

19.0

g/l

133.0

138.6

38.02

1785

17039

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

254

2.57

10.98

1.3

u/ml

6.7

5.4

0.22

118

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

232

1467

1.66

10.95

3.0

2.9

g/l

0.2

2.45

218

1383

(3035941) MCH [Entitic mass]

1800

17245

2.64

10.93

30.7

18.8

30.1

30.2

1.27

1786

17039

(3002256) Pathology report gross observation

256

1663

1.63

10.86

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

258

2.53

10.64

1.3

u/ml

4.7

3.8

0.12

(42870588) Differential panel, method unspecified - Blood

678

5398

1.40

10.57

7.6

7.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

168

2.91

10.47

2.8

2.9

nmol/l

0.9

0.8

0.14

121

(3018010) Neutrophils/100 leukocytes in Blood

898

7512

1.38

10.32

7.8

6.9

58.0

55.3

9.52

858

7112

(3002030) Lymphocytes/100 leukocytes in Blood

908

7625

1.37

10.11

7.9

7.1

26.5

29.8

15.69

866

7194

(3030467) Casts [#/volume] in Urine by Automated count

525

4028

1.42

10.00

3.6

3.3

e6/l

0.4

0.22

422

3012

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1504

13775

1.49

9.94

4.4

3.8

mmol/l

1.3

0.14

1432

12845

(3018095) Leukocytes [#/volume] in Urine

640

5089

1.39

9.89

4.1

4.0

e6/l

109.3

70.7

0.33

488

3607

(3003338) MCHC [Mass/volume]

1495

13687

1.48

9.80

28.4

16.3

g/l

333.4

334.4

4.37

1487

13588

(4268621)

175

2.79

9.74

2.4

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1230

10887

1.39

9.66

3.8

3.6

pmol/l

15.0

14.7

3.68

1137

9972

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

248

2.42

9.02

1.6

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

549

4309

1.39

9.00

3.1

2.7

u/l

59.7

57.2

0.41

509

4042

(3000494) Fungus identified in Specimen by Culture

255

1728

1.55

8.97

1.7

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

2.34

8.94

1.5

1.6

—

(36304419) Bacteria [Presence] in Urine

512

3985

1.39

8.79

3.6

3.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

256

1758

1.53

8.46

4.0

3.7

umol/l

9.9

8.2

0.73

235

1540

(3026782) Osmolality of Urine

378

2808

1.43

8.42

2.9

2.8

mosm/kgh2o

578.5

574.8

0.10

315

2408

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1545

14362

1.46

8.18

4.8

4.2

mmol/l

4.4

4.6

10.69

1482

13507

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

171

2.61

7.95

3.3

2.5

32.5

33.0

0.35

171

(3022313) Gas panel - Capillary blood

174

1109

1.63

7.93

10.5

6.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

396

2.04

7.93

9.7

8.0

iu/ml

1509.5

354.4

0.91

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

286

2.21

7.71

1.5

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1018

8912

1.32

7.65

4.5

3.9

e6/l

27.6

1117.2

1.19

134

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

224

2.36

7.58

1.5

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

208

1402

1.54

7.47

10.6

6.4

kpa

5.1

0.33

203

1328

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

203

1362

1.55

7.44

10.7

6.5

mmol/l

2.1

1.3

3.69

159

1011

(3010375) cycloSPORINE [Mass/volume] in Blood

115

2.90

7.33

24.6

33.3

ug/l

157.1

133.0

0.79

101

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

2.38

7.32

1.5

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

132

802

1.70

7.24

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1561

14619

1.43

7.18

25.3

14.1

39.8

40.8

6.45

1243

11456

(3042733) HLA Ab [Presence] in Serum

3.14

7.14

4.1

4.3

—

(3009343) pH of Capillary blood

205

1392

1.53

7.12

10.7

6.4

7.4

0.10

130

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

333

2493

1.41

7.00

3.1

3.0

e6/l

0.8

0.9

0.38

220

1401

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1550

14518

1.42

6.94

5.3

4.5

mmol/l

2.7

2.8

7.01

1486

13562

(3034426) Prothrombin time (PT)

3.71

6.91

1.1

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

196

2.38

6.90

1.5

1.6

—

(3011648) Oxygen content in Venous blood

161

2.52

6.78

8.2

9.3

11.7

11.5

0.11

161

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1526

14278

1.39

6.67

4.8

4.1

mmol/l

1.4

1.96

1462

13352

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.01

6.66

1.6

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

328

2.02

6.46

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

328

2.02

6.46

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

130

2.65

6.40

1.5

e6/l

2148.6

1898.7

0.14

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

166

2.44

6.37

1.9

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1472

13728

1.35

6.29

4.2

4.1

mmol/l

5.9

0.53

1368

12663

(3051593) INR in Capillary blood by Coagulation assay

4.24

6.28

13.7

16.2

—

(3052851) Hemolysis interference index of Serum or Plasma

410

1.89

6.24

4.8

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

144

930

1.59

6.24

1.9

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1403

13011

1.32

6.09

5.2

mmol/mol

38.1

39.4

6.31

1329

12213

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

423

1.86

5.99

2.2

1.7

u/ml

81.1

117.5

1.54

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

446

1.83

5.95

2.2

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1078

9687

1.27

5.85

4.4

4.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

360

2817

1.34

5.68

1.5

nmol/l

20.8

20.4

0.22

322

2429

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.72

5.64

4.7

5.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

452

3660

1.31

5.61

3.2

3.0

umol/l

2429.9

5429.3

1.43

420

3260

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

127

819

1.59

5.56

3.6

3.5

pmol/l

4.5

4.7

1.37

112

737

(3028308) Erythrocytes [#/volume] in Pleural fluid

116

2.61

5.56

1.5

e6/l

71740.5

29733.7

0.57

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.79

5.47

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

100

2.72

5.44

1.4

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

419

3381

1.31

5.30

5.1

4.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.36

5.29

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.64

5.26

1.1

1.6

—

(3012441) Differential panel - Pleural fluid

115

2.55

5.13

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

615

5229

1.26

5.13

1.8

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

447

3662

1.29

5.02

4.3

3.6

estimate

0.0

0.29

140

1269

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.09

4.79

1.2

1.0

69.8

91.2

1.77

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

187

1354

1.42

4.72

3.4

3.2

—

(40761535) Cells panel - Urine sediment

152

1063

1.47

4.62

3.9

3.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

409

1.74

4.52

6.1

4.6

mmol/l

23.7

24.6

0.86

364

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

174

2.15

4.51

1.9

3.3

13.6

11.1

0.55

117

(3026008) Bacteria identified in Urine by Culture

406

3328

1.28

4.49

3.1

2.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

494

1.67

4.48

1.9

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

182

1324

1.42

4.48

4.1

2.9

g/l

10.1

10.2

0.14

176

1227

(3000330) Specific gravity of Urine by Test strip

549

1.63

4.46

3.2

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

293

1.87

4.45

1.4

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

475

1.67

4.35

1.5

1.8

—

(3024471) HLA-A [Type]

2.60

4.31

1.0

—

(3024932) HLA-DR beta [Type]

2.60

4.31

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.28

4.19

1.3

1.1

83.4

89.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

301

2394

1.31

4.18

3.2

e6/l

2.1

1.6

0.48

189

1308

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.45

3.98

1.7

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

480

1.63

3.95

2.0

1.6

u/ml

274.4

233.4

0.56

261

(3035285) Chloride [Moles/volume] in Venous blood

144

2.17

3.93

3.4

2.6

mmol/l

106.7

105.4

0.99

144

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

1.95

3.93

1.3

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

145

2.16

3.87

3.4

2.6

mmol/l

3.9

4.1

1.40

145

(3033705) Calcium.ionized [Moles/volume] in Venous blood

140

2.16

3.77

3.4

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

391

3254

1.26

3.76

4.1

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

512

1.59

3.71

1.7

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.80

3.69

1.3

57.5

88.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

442

1.63

3.68

2.4

2.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.62

3.64

1.5

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

144

1047

1.41

3.59

2.1

1.9

g/l

1.2

0.08

139

977

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.80

3.56

1.0

—

(3035880) pH of Pleural fluid

2.82

3.52

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

141

1030

1.40

3.43

2.3

2.8

g/l

63.8

66.4

3.15

135

953

(3008037) Lactate [Moles/volume] in Venous blood

260

1.79

3.40

4.6

3.6

mmol/l

1.4

1.6

0.91

254

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.59

3.38

1.5

1.2

—

(3000012) Reticulocyte production index

2.59

3.38

1.4

1.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

361

1.65

3.31

1.8

1.9

—

(3011412) CD3 cells [#/volume] in Blood

212

1.86

3.27

2.2

3.4

e9/l

0.8

1.4

4.01

129

(3000093) Morphology [Interpretation] in Blood Narrative

142

2.06

3.27

1.1

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

765

6891

1.19

3.24

3.9

3.3

estimate

0.0

0.50

149

1278

(3021601) Nitrite [Presence] in Urine by Test strip

765

6895

1.19

3.21

5.1

4.5

estimate

0.0

0.50

153

1329

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.58

3.19

1.7

1.3

ug/l

170.8

107.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

215

1.83

3.14

1.5

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

256

2069

1.28

3.14

1.7

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

137

1014

1.38

3.11

4.5

4.4

mmol/l

1.2

0.19

126

887

(1616796) Gas panel - Central venous blood

337

1.65

3.08

5.5

4.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

160

1.95

3.05

1.2

1.5

pmol/l

406.7

377.5

0.08

131

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

2.51

3.04

1.4

1.5

—

(3014891) Appearance of Pleural fluid

5.85

3.02

2.0

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

507

1.52

2.99

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

264

1.72

2.97

1.2

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

318

1.65

2.95

4.9

5.2

kpa

8.7

8.8

0.16

313

(3012501) Base excess in Blood by calculation

318

1.65

2.95

4.9

5.2

mmol/l

1.7

2.4

1.33

204

(3013290) Carbon dioxide [Partial pressure] in Blood

319

1.65

2.92

4.9

5.2

kpa

5.0

0.15

314

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

366

1.60

2.91

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

222

1.77

2.86

3.0

2.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

171

1.89

2.86

2.2

3.6

e9/l

0.2

0.15

141

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

595

5295

1.18

2.82

4.0

3.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

494

4331

1.19

2.77

3.3

3.4

mmol/l

2.3

2.4

0.94

443

3866

(3040893) Potassium [Moles/volume] in Capillary blood

5.01

2.73

2.4

3.4

mmol/l

4.1

4.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

341

1.60

2.72

2.7

2.5

g/l

132.1

133.3

0.13

260

(3009261) Glucose [Presence] in Urine by Test strip

765

6967

1.17

2.70

3.9

3.3

estimate

0.0

0.80

152

1249

(3028271) Lactate [Moles/volume] in Capillary blood

228

1.73

2.64

1.8

2.2

mmol/l

1.6

0.16

221

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

784

1.39

2.62

1.8

1.5

—

(4034850)

426

1.52

2.59

14.8

8.7

—

(3025159) Blasts/100 leukocytes in Blood

140

1073

1.33

2.58

4.7

5.0

0.0

0.4

0.69

279

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

575

1.45

2.57

1.3

—

(3021901) Oxygen saturation in Capillary blood

285

1.63

2.52

5.2

3.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

108

2.05

2.52

1.5

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

638

1.41

2.49

2.1

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

263

1.65

2.48

3.3

4.1

—

(3000060) B lymphocytes [#/volume] in Blood

116

1.99

2.45

2.2

3.7

e6/l

293.1

329.1

0.26

(3003181) Sodium [Moles/volume] in Urine

249

1.66

2.44

1.3

1.8

mmol/l

76.1

70.5

0.25

211

(4094501)

392

1.52

2.42

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

174

1.79

2.42

2.3

3.6

e6/l

315.5

609.3

2.91

141

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1179

11145

1.16

2.42

3.1

3.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

1.95

2.40

1.3

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

1.95

2.40

1.3

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

1.95

2.40

1.3

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

443

1.48

2.37

1.3

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

152

1195

1.30

2.35

4.6

4.8

0.9

0.8

0.09

354

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.15

2.35

1.3

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

133

1032

1.31

2.28

6.0

5.5

ng/l

85.0

79.1

0.37

125

953

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.69

2.27

2.7

2.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

139

1086

1.30

2.26

4.4

4.5

0.8

0.5

0.63

260

(3021440) Promyelocytes/100 leukocytes in Blood

144

1131

1.30

2.26

4.6

4.9

0.2

0.1

0.22

325

(3025941) Bacteria identified in Stool by Culture

107

807

1.35

2.23

1.3

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.11

2.22

2.2

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.51

2.18

1.8

2.9

umol/l

26.7

32.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.51

2.18

1.3

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

274

1.58

2.15

2.6

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

445

1.45

2.14

1.3

1.1

—

(3000492) Spirometry study

189

1550

1.24

2.09

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

373

1.49

2.09

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.01

2.07

1.6

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

2.07

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

2.07

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

380

0.55

2.06

1.2

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

176

1.72

2.06

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

449

1.44

2.06

1.3

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

560

5075

1.15

1.99

1.9

pmol/l

94.7

95.5

0.19

330

2783

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1090

10321

1.14

1.97

3.7

3.4

u/l

49.8

49.2

0.11

1029

9779

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

201

0.44

1.96

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

246

2092

1.20

1.93

1.6

1.7

nmol/l

1317.5

1169.6

1.76

196

1615

(3023419) Bacteria identified in Sputum by Culture

180

1.68

1.92

2.2

3.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

135

1.79

1.91

1.4

1.6

umol/l

12.3

12.6

0.10

129

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

227

1.60

1.91

7.4

4.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

142

0.35

1.87

1.0

2.1

—

(4146454)

143

0.35

1.87

4.2

2.7

—

(3020393) Adenovirus Ag [Presence] in Stool

2.06

1.80

2.2

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.06

1.80

1.3

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

296

2575

1.18

1.80

1.6

—

(40768806) Pleura Pathology biopsy report

116

1.82

1.78

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

285

0.52

1.76

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.03

1.75

1.3

1.8

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

3.34

1.74

1.5

2.3

umol/l

30.3

28.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

191

0.47

1.73

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

178

1.64

1.73

1.6

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

307

1.48

1.71

3.3

2.8

17.1

16.9

0.11

177

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

1.81

1.68

2.6

2.7

31.7

40.4

—

(3009871) Measles virus Ab [Titer] in Serum

2.19

1.67

1.5

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

279

0.53

1.66

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

452

1.38

1.66

1.4

titre

94.4

84.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

3.16

1.66

1.5

2.2

umol/l

37.8

34.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

277

1.49

1.64

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

277

0.54

1.63

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

636

0.70

1.59

3.2

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

420

3792

1.14

1.55

1.7

mmol/l

1.4

0.01

363

3245

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

209

1.54

1.51

1.6

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

292

1.45

1.49

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.44

1.48

1.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.13

1.44

1.0

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

247

2160

1.17

1.43

2.0

3.1

mmol/l

2.4

0.72

208

1893

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

153

0.46

1.43

1.4

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

287

1.44

1.41

2.1

2.3

—

4.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

138

0.43

1.40

1.0

1.1

mg/l

274.3

298.5

—

118

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

230

1.49

1.39

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.42

1.39

1.1

1.2

—

(4010399)

119

977

1.23

1.38

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.20

1.37

1.6

2.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

346

0.63

1.35

1.2

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

1.76

1.35

1.8

2.0

mg/l

3.6

3.5

0.03

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

183

1.54

1.34

2.0

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

567

1.30

1.34

1.8

2.4

u/l

9200.9

4450.9

0.44

212

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

345

0.63

1.33

1.2

1.4

—

(3045414) Leukocytes [Presence] in Urine

577

1.29

1.32

2.1

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

344

0.64

1.32

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

344

0.64

1.32

1.2

1.4

—

(3042631) Mycobacterium sp identified in Specimen

168

1.56

1.31

2.4

3.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.50

1.30

1.3

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1102

0.80

1.29

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

746

0.76

1.28

2.4

—

(1761868) Lipid panel - Serum or Plasma

520

5606

0.90

1.28

2.7

2.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

131

0.46

1.28

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

122

1.65

1.27

2.2

2.6

—

(3037522) Nuclear Ab [Titer] in Serum

228

2005

1.16

1.25

1.4

titre

484.2

490.7

0.02

390

(3022621) pH of Urine by Test strip

791

1.24

1.22

3.9

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.05

1.22

1.5

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

522

0.72

1.19

1.2

1.3

miu/ml

101.1

220.1

2.76

237

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.75

1.19

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

1.18

1.0

1.3

—

(40757373) Influenza virus identified in Isolate

2.31

1.18

1.7

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

137

1606

0.84

1.17

1.7

—

(3027944) Amphetamines [Presence] in Urine

934

0.79

1.17

2.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

182

1.49

1.16

1.3

mmol/l

7.5

7.4

0.06

134

(40768793) Breast Pathology biopsy report

196

0.56

1.12

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

951

0.80

1.12

2.1

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

259

1.40

1.12

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

280

0.64

1.09

1.1

u/ml

2.8

3.9

—

124

(3044007) Cell count panel - Peritoneal fluid

1.95

1.08

1.1

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

181

0.55

1.08

1.1

1.0

—

(3028300) Cannabinoids [Presence] in Urine

954

0.81

1.05

2.4

2.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1.60

1.05

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

113

1.60

1.05

1.2

1.6

g/l

1.0

0.11

113

(3000764) Benzodiazepines [Presence] in Urine

943

0.81

1.05

2.1

2.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

129

1.56

1.05

3.0

2.9

umol/l

1.7

1.8

0.17

124

(3044927) Protein electrophoresis panel - Urine

125

0.48

1.04

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.28

1.03

1.0

1.1

—

(3008898) HLA-B27 [Presence]

620

0.77

1.03

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

334

0.68

1.02

1.4

—

(3021788) Differential panel - Synovial fluid

230

1.40

1.01

1.3

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.69

1.01

1.0

1.2

iu/ml

181.8

227.4

0.38

(3016879) Cocaine [Presence] in Urine

882

0.81

1.00

2.1

2.4

—

(4306422)

249

1.37

0.98

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.97

0.0

1.5

—

9.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.2

—

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

206

2303

0.88

0.96

1.9

1.6

1.5

0.39

186

2064

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

116

1.56

0.96

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

416

1.28

0.96

1.4

1.5

ug/g

272.3

297.9

0.32

249

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.78

0.94

1.2

—

(4027681)

116

0.52

0.94

1.3

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

348

1.30

0.92

3.5

mg/l

31.8

73.8

1.50

274

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

167

1.44

0.92

2.0

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.15

0.91

1.3

1.0

—

(40761536) Microorganisms panel - Urine sediment

137

1193

1.16

0.90

3.3

3.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

349

1.30

0.90

3.5

mg/l

35.3

43.4

0.31

277

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.60

0.90

1.2

1.1

ratio

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

152

1337

1.15

0.88

1.5

—

(21494755) Public health laboratory ask at order entry panel

162

1826

0.88

0.87

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

111

1.54

0.87

4.9

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

111

1.54

0.87

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

276

0.69

0.87

1.0

1.1

u/ml

0.1

0.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

405

1.27

0.86

1.5

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

128

1.49

0.86

1.8

1.3

e6/l

357257.6

47031.3

0.49

(3034274) Bile acid [Moles/volume] in Serum --fasting

204

1.38

0.85

3.5

3.7

umol/l

14.3

9.8

0.51

165

(3029396) Erythrocyte agglutination [Presence] in Blood

1.94

0.84

2.3

3.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

309

1.30

0.84

3.1

3.9

58.1

55.3

0.67

309

(3041096) Erythrocytes [Presence] in Urine by Automated

409

3817

1.09

0.84

3.2

2.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

283

2595

1.11

0.84

1.5

1.6

pmol/l

83544734.4

33950765.0

0.36

237

2215

(3030905) Polymorphonuclear cells [#/volume] in Blood

301

1.30

0.83

2.7

3.6

e9/l

3.9

4.0

0.03

301

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

214

1.36

0.82

1.3

1.4

pmol/l

77.9

155.1

0.73

208

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.74

0.82

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.74

0.82

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.70

0.82

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1.51

0.82

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

113

1.51

0.82

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

347

1.27

0.80

1.7

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.82

0.79

2.2

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

260

1.31

0.78

4.1

3.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

322

1.28

0.78

1.9

1.7

e6/l

15950.8

14310.7

0.11

236

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

439

1.24

0.77

2.1

1.8

—

(3023410) Appearance of Cerebral spinal fluid

222

0.67

0.77

1.4

3.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

157

1.41

0.76

1.0

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.54

0.75

2.6

2.9

u/ml

1348.6

1044.6

0.17

(3003327) Ova and parasites identified in Stool by Light microscopy

569

1.20

0.75

1.9

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.67

0.74

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

344

3205

1.09

0.74

2.1

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

380

0.76

0.74

1.6

2.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

116

1.47

0.74

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

116

1.47

0.74

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.64

0.73

1.6

2.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.64

0.73

1.7

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.64

0.73

4.2

2.8

—

(3019150) Specific gravity of Urine by Refractometry

331

3081

1.09

0.73

4.6

3.4

kg/l

1.0

0.98

421

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

525

1.21

0.72

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.80

0.72

1.1

3.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

317

1.27

0.72

1.3

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.72

6.2

8.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.67

0.72

2.3

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.55

0.69

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.55

0.69

1.2

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

431

0.78

0.69

3.2

3.1

—

(3033799) Differential panel - Peritoneal fluid

1.67

0.68

1.1

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.53

0.68

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

119

1.43

0.67

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

260

1.27

0.64

1.2

—

(3045142) Bone marrow Pathology biopsy report

189

0.69

0.64

1.2

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.52

0.62

2.8

4.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

164

1.35

0.62

1.2

—

296.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

480

1.19

0.61

3.1

3.7

u/ml

212.0

2988.7

0.73

410

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.67

0.61

1.6

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

109

967

1.13

0.61

1.1

1.3

au/ml

23.0

53.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

301

0.76

0.61

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

289

1.25

0.61

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

199

2162

0.91

0.61

1.2

u/ml

6.6

11.5

0.63

863

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

334

0.78

0.60

2.4

2.5

ug/min

130.6

110.5

0.11

199

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.60

0.0

9.3

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

4.4

—

4.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.59

0.0

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.57

0.58

1.1

1.3

—

67.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

0.62

0.58

1.3

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.72

0.57

1.5

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

656

0.85

0.56

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

218

0.73

0.56

1.9

2.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.51

0.56

1.1

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.57

0.56

1.2

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

339

1.21

0.55

1.8

2.5

g/l

0.0

0.50

318

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

365

3457

1.07

0.54

1.8

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

642

0.85

0.54

1.5

1.8

mg/l

2.6

3.9

1.21

452

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

160

1.32

0.53

1.0

1.3

nmol/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

350

1.20

0.52

1.1

1.2

u/ml

2.1

9.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

161

1.31

0.51

1.0

1.4

u/ml

0.9

2.6

—

(44813793)

136

0.66

0.51

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

315

1.21

0.50

1.2

2.5

g/l

0.0

0.00

294

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.39

0.50

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

145

1581

0.91

0.50

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.50

3.3

3.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.46

0.50

3.3

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.50

3.3

3.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

400

0.82

0.49

1.6

2.5

e6/l

223.8

1118.9

1.00

310

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

400

0.82

0.49

1.5

2.4

e6/l

3.2

33.2

1.22

298

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.52

0.48

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

364

1.19

0.47

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

462

0.84

0.47

1.0

1.2

u/ml

2.8

7.4

2.92

288

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.47

0.47

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.47

0.47

1.3

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.46

0.46

1.0

1.4

ug/l

12.4

8.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

487

4678

1.06

0.46

4.2

3.8

23.6

21.4

1.70

231

2043

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

337

1.19

0.46

2.1

1.8

iu/l

2.4

5.6

3.59

119

(3002523) Influenza virus A Ag [Presence] in Specimen

365

1.18

0.46

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.60

0.45

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.60

0.45

1.2

1.3

nmol/l

117.4

145.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

103

1.36

0.45

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

103

1.36

0.45

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

459

0.85

0.44

1.4

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.37

0.44

2.7

6.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

128

0.70

0.43

1.7

1.4

mmol/l

2.6

2.0

—

121

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

130

0.69

0.43

1.0

mmol/l

19.4

19.7

—

125

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

224

2106

1.07

0.43

1.5

—

(3049717) Cytology report of Urine Cyto stain

499

1.15

0.43

2.4

2.5

—

(4015189)

1.61

0.43

1.6

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

446

0.85

0.42

1.0

1.2

u/ml

0.9

1.1

0.16

259

(3015171) Extractable nuclear Ab [Units/volume] in Serum

528

1.14

0.42

1.2

u/ml

0.3

0.9

0.66

(3010726) Horse dander IgE Ab [Units/volume] in Serum

435

0.85

0.42

1.0

1.1

u/ml

6.0

4.0

—

125

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

313

1.19

0.42

1.2

2.6

g/l

0.0

0.00

293

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.56

0.42

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

316

0.82

0.42

1.0

1.1

u/ml

1.9

6.4

—

144

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.41

0.0

3.0

—

0.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

511

1.14

0.40

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.40

0.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

204

1.23

0.40

1.6

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

115

1055

1.10

0.40

2.2

2.3

au/ml

19.6

19.9

—

(36660697) Celiac disease serology panel - Serum

132

1427

0.92

0.40

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

123

1.30

0.40

1.4

u/ml

4.6

0.3

—

(3002619) Bacteria identified in Specimen by Culture

1.47

0.40

1.2

—

(3032641) Amino acids panel - Urine

0.00

0.40

0.0

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.40

0.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.37

0.40

1.0

—

(1002224) Polysomnography panel

702

1.12

0.39

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.34

0.39

1.8

2.5

u/field

0.2

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

105

0.67

0.39

1.0

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

532

1.13

0.39

1.1

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

416

4001

1.05

0.39

3.7

4.1

mg/mmol

8.3

13.6

0.62

278

2675

(3019832) Treponema pallidum Ab [Presence] in Serum

150

1609

0.93

0.38

2.0

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

364

3489

1.05

0.38

1.7

1.6

g/l

2.4

2.3

0.45

248

2102

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

148

1377

1.08

0.38

2.6

u/l

31.9

73.8

0.66

126

1200

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.38

0.38

1.0

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

179

1.23

0.37

1.0

1.4

nmol/l

0.5

0.6

0.86

171

(3024263) Appearance of Synovial fluid

1.27

0.36

2.1

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.65

0.35

1.2

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

1.30

0.35

1.1

1.2

—

(3006598) pH of Arterial cord blood

123

0.73

0.35

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

245

1.19

0.35

2.8

3.6

u/ml

780.8

233.8

0.33

231

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

0.72

0.35

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

125

0.72

0.35

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

178

0.78

0.34

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.36

0.34

1.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

126

1173

1.08

0.34

3.1

4.4

ug/l

68.7

21.7

0.34

100

960

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

133

0.75

0.33

3.4

4.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

109

1.29

0.33

1.1

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

219

2303

0.94

0.33

1.2

1.3

iu/ml

35.9

29.6

0.28

687

(3017446) Testosterone [Moles/volume] in Serum or Plasma

166

1761

0.94

0.33

2.2

2.3

nmol/l

12.8

13.4

0.44

149

1571

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

521

1.12

0.32

1.6

iu/ml

12.4

0.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

379

1.14

0.32

1.6

2.6

g/l

0.3

1.2

2.39

342

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

192

1.20

0.32

1.2

1.1

80.2

96.4

1.51

182

(21494890) Protein electrophoresis panel - 24 hour Urine

119

1.26

0.31

1.9

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

110

1.27

0.31

2.3

2.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

110

1.27

0.31

2.3

2.6

—

(3012516) Albumin [Mass/volume] in Urine

396

3827

1.04

0.31

3.3

3.4

mg/l

503.0

224.9

0.52

263

2588

(3014599) Egg white IgE Ab [Units/volume] in Serum

156

1.22

0.31

1.1

1.4

u/ml

11.4

3.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

175

0.80

0.31

1.9

1.6

—

(40768795) Lymph node Pathology biopsy report

131

0.76

0.31

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

147

1560

0.94

0.30

4.2

4.1

31.8

31.0

0.34

111

1100

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

546

0.89

0.30

1.7

1.9

pmol/l

203.8

216.3

0.38

518

(3023511) Choriogonadotropin [Units/volume] in Urine

278

1.15

0.29

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

157

1484

1.06

0.29

2.6

2.4

nmol/l

366.3

361.4

0.10

145

1392

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.32

0.28

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.32

0.28

1.1

93.1

83.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

646

0.91

0.27

1.8

2.1

u/l

33.9

40.0

1.52

581

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

1.5

2.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

1.5

2.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

1.5

2.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

1.5

2.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

178

1.18

0.26

1.0

1.4

nmol/l

—

0.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.68

0.26

7.0

7.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

768

0.92

0.25

1.5

1.6

—

(3004451) EKG impression Narrative

1.25

0.25

1.2

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.23

0.25

1.1

1.4

u/l

166.4

405.5

—

(3004616) Nuclear Ab [Presence] in Serum

159

0.82

0.25

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

105

1.24

0.24

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

329

0.88

0.24

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

463

4516

1.03

0.24

3.2

3.6

mmol/l

7.8

8.4

1.68

401

3889

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

152

1.19

0.23

1.5

1.6

72.8

58.0

1.07

102

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

1.11

0.23

1.9

2.4

g/l

3.4

3.1

1.14

328

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

143

1.19

0.23

1.1

1.3

nmol/l

1.8

1.4

0.63

125

(3024980) IgG subclass 4 [Mass/volume] in Serum

294

1.12

0.23

1.6

1.7

g/l

0.8

0.00

229

(3037556) Urate [Mass/volume] in Serum or Plasma

1.28

0.23

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

285

1.12

0.22

1.1

1.2

u/ml

22.8

35.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

181

1.16

0.22

1.5

1.3

g/l

0.3

0.4

0.98

127

(4062490)

181

1.16

0.22

1.5

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

181

1.16

0.22

1.5

1.3

g/l

1.9

2.7

1.91

128

(3027135) IgG subclass 1 [Mass/volume] in Serum

181

1.16

0.22

1.5

1.3

g/l

7.3

6.6

0.23

128

(3015183) Erythrocyte sedimentation rate

0.76

0.22

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.74

0.22

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

295

1.12

0.22

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

178

0.84

0.22

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

172

1.16

0.22

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

603

1.08

0.22

3.3

5.2

g/l

0.3

0.02

340

(3009214) Lutropin [Units/volume] in Serum or Plasma

699

0.93

0.21

2.1

1.7

u/l

7.7

6.6

0.34

535

(44816559) Phosphatidylethanol [Mass/volume] in Blood

353

1.11

0.21

2.0

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.21

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.9

—

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

13.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

597

5858

1.03

0.21

4.2

4.3

ug/l

2.0

2.3

0.71

532

5309

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

13.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

893

0.94

0.21

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

838

1.06

0.21

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

293

0.89

0.21

1.0

1.1

u/ml

11.2

6.9

—

138

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.5

—

(40768441) Liver Pathology biopsy report

117

1.20

0.20

1.4

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.25

0.20

1.7

2.2

umol/l

24.0

17.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.25

0.20

1.0

1.1

—

(40768443) Skin Pathology biopsy report

538

1.08

0.20

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

354

3450

1.03

0.20

2.9

2.8

ug/l

0.8

0.7

0.36

210

2118

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

0.79

0.20

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.20

0.19

1.7

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

103

978

1.06

0.19

1.3

1.2

iu/ml

97.4

155.2

1.17

357

(3008757) Leukocyte morphology finding [Identifier] in Blood

207

0.87

0.19

3.1

4.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

165

1.15

0.19

1.1

1.4

—

(3045424) Erythrocytes [Presence] in Urine

248

0.89

0.18

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

290

1.11

0.18

1.0

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

271

1.11

0.18

1.9

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.73

0.17

1.0

1.6

—

8.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

215

1.12

0.16

1.4

1.6

nmol/l

0.3

0.03

170

(3019225) pH of Specimen

114

1189

0.96

0.16

2.8

4.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

350

1.09

0.16

1.2

2.4

g/l

37.5

38.1

0.22

308

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.11

0.16

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.11

0.16

1.3

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

1.17

0.15

1.1

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.21

0.15

1.4

1.6

iu/ml

—

1458281.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

307

0.91

0.15

1.4

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.14

0.15

2.7

2.1

nmol/l

0.0

0.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

789

0.95

0.15

2.6

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

210

2042

1.03

0.15

2.5

2.9

ug/g

114.7

133.7

0.39

164

1679

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.10

0.15

1.2

3.0

ug/l

19.4

410.5

—

(4024509)

1.10

0.15

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

306

0.91

0.14

1.6

1.5

—

(3044941) Cell count panel - Synovial fluid

217

1.11

0.14

1.9

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

131

1.15

0.14

1.7

2.2

mg/l

19.9

18.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

122

1.15

0.13

2.0

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.81

0.13

1.8

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

325

1.08

0.13

1.3

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

180

1.11

0.13

1.8

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

1.07

0.13

1.9

2.4

g/l

10.0

10.5

0.40

353

(3042111) Morphology [Interpretation] in Bone marrow Narrative

219

1.10

0.12

2.0

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

229

1.09

0.12

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

372

3780

0.98

0.12

1.3

1.4

u/ml

2.5

2.0

0.25

104

945

(3024522) Salmonella sp identified in Specimen by Organism specific culture

168

0.89

0.11

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

495

0.95

0.10

1.1

1.2

u/ml

0.5

2.3

2.65

266

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

1.06

0.10

1.9

2.4

g/l

7.3

7.2

0.06

337

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

1.06

0.10

1.9

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

1.06

0.10

1.9

2.4

g/l

3.7

3.8

0.44

322

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

158

1541

1.03

0.10

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

156

0.90

0.10

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.14

0.10

1.2

1.0

u/ml

32.6

42.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

111

1078

1.03

0.09

2.7

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

271

1.07

0.09

1.9

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

135

1.11

0.09

2.3

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

174

1.09

0.09

1.1

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

299

0.94

0.09

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

872

1.03

0.09

2.7

2.0

—

(40768797) Stomach Pathology biopsy report

180

1836

0.98

0.09

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.05

0.08

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

107

1.12

0.08

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

302

1.06

0.08

3.5

mg/l

14.1

26.7

4.48

191

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.03

0.08

1.0

g/l

165.7

162.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.83

0.08

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.86

0.07

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.84

0.07

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.12

0.07

1.2

1.3

—

(3017704) Immunofixation for Urine

0.81

0.07

1.8

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.05

0.07

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.03

0.07

1.0

1.5

ug/l

5.1

8.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

294

1.06

0.07

4.5

3.5

nmol/l

21.5

22.5

0.15

284

(3022145) Colonoscopy Study observation

151

1538

0.98

0.07

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.89

0.06

5.3

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.89

0.06

10.5

5.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

0.87

0.06

2.3

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

246

1.06

0.06

1.1

1.2

—

(21494434) Karyotype in Bone marrow

148

1.08

0.06

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

671

1.03

0.06

2.0

1.7

iu/l

25.9

18.3

1.08

525

(3017732) Neutrophils [#/volume] in Blood

991

0.98

0.06

2.5

3.0

e9/l

4.0

4.1

0.29

814

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

662

1.03

0.05

1.6

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

139

1.08

0.05

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

228

1.05

0.05

1.1

1.2

u/l

18.0

46.3

1.29

197

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

199

1.06

0.04

1.2

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

571

5682

1.01

0.04

2.7

2.5

nmol/l

76.8

73.6

1.82

523

5197

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

219

2209

0.99

0.03

2.0

2.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

139

0.93

0.03

11.1

14.8

nmol/l

945.9

784.4

0.96

133

(3037756) Immunofixation for Serum or Plasma

240

0.96

0.03

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

149

0.94

0.03

1.0

1.1

—

7.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

421

0.97

0.03

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

169

0.95

0.03

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

108

0.93

0.03

1.0

1.3

u/ml

0.1

33.5

—

(3025130) Human papilloma virus identified in Specimen

133

1.05

0.01

1.9

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

167

0.96

0.01

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

167

0.96

0.01

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

201

2020

0.99

0.01

1.9

2.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

106

0.94

0.01

4.7

4.4

ug/l

4.7

1.7

—

100

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

166

0.96

0.00

1.4

1.5

—

(4035726)

113

1136

0.99

0.00

2.1

1.4

—

(40768446) Kidney Pathology biopsy report

1.02

0.00

2.2

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

941

1.00

0.00

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

168

1.01

0.00

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

111

0.99

0.00

2.1

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

101

0.99

0.00

1.2

1.1

—

95.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

165

0.97

0.00

1.4

1.6

—

(4198724)

129

1.01

0.00

1.7

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

199

1.00

0.00

1.3

1.4

pmol/l

110.1

65.8

—

(3012565) Volume of 24 hour Urine

0.93

0.00

2.0

3.1

1907.7

2079.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

199.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

5.4

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.0

3.8

—

0.6

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

3.5

—

139.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

2.2

—

(3017569) Oxygen content in Arterial blood

1.01

0.00

2.6

3.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

2.1

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

8.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.85

0.00

1.0

1.2

u/ml

0.0

10.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.0

1.7

—

364.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.94

0.00

1.8

3.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.00

0.00

1.1

1.0

miu/ml

1442.0

1475.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

420.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.86

0.00

1.0

1.3

u/ml

0.5

3.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.8

—

(3028433) Virus identified in Specimen by Culture

0.94

0.00

1.2

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.02

0.00

1.2

2.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

4.3

—

(3014271) Vancomycin [Susceptibility]

0.91

0.00

2.4

2.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

470.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.8

3.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.85

0.00

1.0

—

(3047189) Immunofixation for 24 hour Urine

1.00

0.00

1.3

1.8

—

(4281824)

0.92

0.00

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.8

3.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.00

0.00

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.94

0.00

1.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_LVOTO_NARROW and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_LVOTO_NARROW	2.247 [1.81, 2.8]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.053

During the follow-up period (1.1.1998 — 31.12.2019), 263 out of 3839 females with Q17_LVOTO_NARROW died.

Males

Parameter	HR [95% CI]	p-value
Q17_LVOTO_NARROW	1.537 [1.3, 1.81]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.082

During the follow-up period (1.1.1998 — 31.12.2019), 418 out of 6581 males with Q17_LVOTO_NARROW died.

Mortality risk

Mortality risk for people of age

years, who have Q17_LVOTO_NARROW.

N-year risk	Females	Males
1	0.212%	0.276%
5	1.202%	1.713%
10	2.968%	4.62%
15	5.465%	8.948%
20	9.766%	15.278%

Relationships between endpoints

↥

Index endpoint: Q17_LVOTO_NARROW – Left ventricular outflow tract obstruction, narrow definition

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Left ventricular outflow tract obstruction, narrow definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints